| Spondylodiscitis due to an emergent fungal pathogen: Blastoschizomyces capitatus, a case report and review of the literature. | |
| | |
MedLine Citation:
|
PMID: 19370350 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
The study includes a case report and a literature review. The main objective of this study is to present a case of spondylodiscitis due to a fungal pathogen, Blastoschizomyces capitatus and to review the published literature on this emergent fungus in etiology of spondylodiscitis, and osteomyelitis. Osteoarticular involvement due to B. capitatus has been reported in six cases, and vertebral involvement has been seen in five of them. All of these cases had underlying malignancy. Infection is usually advanced at presentation. Case notes and online databases were reviewed. Organism was isolated from bone material in all of the cases and antibiotic treatment by antifungal agents cured the infection. We present another case of infectious spondylodiscitis due to B. capitaus, which is reported first in Turkey and tried to attract attendance to this emergent fungal pathogen as an etiologic agent of spine infections in cancer patients. |
| | |
Authors:
|
Aygul Dogan Celik; Resat Ozaras; Serda Kantarcioglu; Ali Mert; Fehmi Tabak; Recep Ozturk |
Publication Detail:
|
Type: Case Reports; Journal Article; Review Date: 2009-04-16 |
Journal Detail:
|
Title: Rheumatology international Volume: 29 ISSN: 1437-160X ISO Abbreviation: Rheumatol. Int. Publication Date: 2009 Aug |
Date Detail:
|
Created Date: 2009-07-29 Completed Date: 2009-11-04 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 8206885 Medline TA: Rheumatol Int Country: Germany |
Other Details:
|
Languages: eng Pagination: 1237-41 Citation Subset: IM |
Affiliation:
|
Trakya University School of Medicine, Edirne, Turkey. adogancelik@yahoo.com.tr |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Aged Amphotericin B / pharmacology Antifungal Agents / pharmacology, therapeutic use Dipodascus / drug effects, isolation & purification, pathogenicity* Discitis / microbiology* Fluconazole / pharmacology Humans Itraconazole / pharmacology Ketoconazole / pharmacology Lumbar Vertebrae / microbiology*, pathology, radiography, surgery Male Microbial Sensitivity Tests Naphthalenes / pharmacology Opportunistic Infections / drug therapy Treatment Outcome |
| Chemical | |
Reg. No./Substance:
|
0/Antifungal Agents; 0/Naphthalenes; 1397-89-3/Amphotericin B; 65277-42-1/Ketoconazole; 84625-61-6/Itraconazole; 86386-73-4/Fluconazole; 91161-71-6/terbinafine |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Validation of the Turkish version of the foot and ankle outcome score.
Next Document: Measuring patients' experiences with rheumatic care: the consumer quality index rheumatoid arthritis...